BioLife Solutions supplies biopreservation media, cold-chain tools and related products used to store and transport cells, tissues and other biologics. Its customers include cell and gene therapy developers, biobanks and research organizations that need reliable cryopreservation and hypothermic storage. The business is built around enabling the logistics and manufacturing of advanced therapies rather than discovering drugs itself.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q2 2025 | 23.4 | — | -15.8 | — |
| Q3 2025 | 28.1 | — | 0.6 | — |
| Q4 2025 | 18.8 | — | 11.1 | — |
| Q1 2026 | 27.5 | — | 1.2 | — |
| Q2 2026 | 28.5 | 21.4% | 45.1 | — |
All markets — KeepWinning global stock screener
Other companies on Nasdaq: The Goodyear Tire & Rubber Company (GT), Braveheart Bio, Inc. (BRVE), Personalis, Inc. (PSNL), Intellia Therapeutics, Inc. (NTLA), Anterix Inc. (ATEX), Septerna, Inc. (SEPN)